Order Article Reprints

Zugbi S, Ganiewich D, Bhattacharyya A, Aschero R, Ottaviani D, Sampor C, Cafferata EG, Mena M, Sgroi M, Winter U, et al. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers. 2020; 12(9):2714. https://doi.org/10.3390/cancers12092714

Zugbi, Santiago, Daiana Ganiewich, Arpita Bhattacharyya, Rosario Aschero, Daniela Ottaviani, Claudia Sampor, Eduardo G. Cafferata, Marcela Mena, Mariana Sgroi, Ursula Winter, and et al. 2020. "Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma" Cancers 12, no. 9: 2714. https://doi.org/10.3390/cancers12092714

Zugbi, S., Ganiewich, D., Bhattacharyya, A., Aschero, R., Ottaviani, D., Sampor, C., Cafferata, E. G., Mena, M., Sgroi, M., Winter, U., Lamas, G., Suñol, M., Daroqui, M., Baialardo, E., Salas, B., Das, A., Fandiño, A., Francis, J. H., Lubieniecki, F., ... Schaiquevich, P. (2020). Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers, 12(9), 2714. https://doi.org/10.3390/cancers12092714